header,class,group,gene,mechanism
gb|AAB57788.1|ARO:3000464|Neisseria_gonorrhoeae_mutant_porin_PIB_(por)_with_reduced_permeability_to_antibiotic_[Neisseria_gonorrhoeae]_,carbapenem;cephalosporin;cephamycin;monobactam;penam;penem;tetracycline antibiotic,General Bacterial Porin with reduced permeability to beta-lactams,Neisseria gonorrhoeae mutant porin PIB (por) with reduced permeability to antibiotic ,reduced permeability to antibiotic
gb|ACF30254.1|ARO:3000817|mtrR_[Neisseria_gonorrhoeae_NCCP11945]_,antibacterial free fatty acids;macrolide antibiotic;penam,major facilitator superfamily (MFS) antibiotic efflux pump;resistance-nodulation-cell division (RND) antibiotic efflux pump,mtrR ,antibiotic efflux
gb|CAA42550.1|ARO:3003028|lmrA_[Streptomyces_lincolnensis]_,lincosamide antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump,lmrA ,antibiotic efflux;antibiotic target alteration
gb|AFC91828.1|ARO:3003041|Streptococcus_pneumoniae_PBP1a_conferring_resistance_to_amoxicillin_[Streptococcus_pneumoniae]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Streptococcus pneumoniae PBP1a conferring resistance to amoxicillin ,antibiotic target alteration
gb|AAL00321.1|ARO:3003042|Streptococcus_pneumoniae_PBP2b_conferring_resistance_to_amoxicillin_[Streptococcus_pneumoniae_R6]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Streptococcus pneumoniae PBP2b conferring resistance to amoxicillin ,antibiotic target alteration
gb|AFC91898.1|ARO:3003043|Streptococcus_pneumoniae_PBP2x_conferring_resistance_to_amoxicillin_[Streptococcus_pneumoniae]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Streptococcus pneumoniae PBP2x conferring resistance to amoxicillin ,antibiotic target alteration
gb|ABD31357.1|ARO:3003074|Staphylococcus_aureus_cls_conferring_resistance_to_daptomycin_[Staphylococcus_aureus_subsp._aureus_NCTC_8325]_,peptide antibiotic,daptomycin resistant cls,Staphylococcus aureus cls conferring resistance to daptomycin ,antibiotic target alteration
gb|AAO82601.1|ARO:3003077|Enterococcus_faecalis_liaF_mutant_conferring_daptomycin_resistance_[Enterococcus_faecalis_V583]_,peptide antibiotic,daptomycin resistant liaF,Enterococcus faecalis liaF mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|AFK58562.1|ARO:3003078|Enterococcus_faecium_liaR_mutant_conferring_daptomycin_resistance_[Enterococcus_faecium_DO]_,peptide antibiotic,daptomycin resistant liaR,Enterococcus faecium liaR mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|AFK58561.1|ARO:3003079|Enterococcus_faecium_liaS_mutant_conferring_daptomycin_resistance_[Enterococcus_faecium_DO]_,peptide antibiotic,daptomycin resistant liaS,Enterococcus faecium liaS mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|ALL09868.1|ARO:3003092|Enterococcus_faecium_cls_conferring_resistance_to_daptomycin_[Enterococcus_faecium]_,peptide antibiotic,daptomycin resistant cls,Enterococcus faecium cls conferring resistance to daptomycin ,antibiotic target alteration
gb|CCP43410.1|ARO:3003283|Mycobacterium_tuberculosis_rpoB_mutants_conferring_resistance_to_rifampicin_[Mycobacterium_tuberculosis_H37Rv]_,peptide antibiotic;rifamycin antibiotic,rifamycin-resistant beta-subunit of RNA polymerase (rpoB),Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin ,antibiotic target alteration;antibiotic target replacement
gb|CAC30845.1|ARO:3003284|Mycobacterium_leprae_rpoB_mutations_conferring_resistance_to_rifampicin_[Mycobacterium_leprae]_,peptide antibiotic;rifamycin antibiotic,rifamycin-resistant beta-subunit of RNA polymerase (rpoB),Mycobacterium leprae rpoB mutations conferring resistance to rifampicin ,antibiotic target alteration;antibiotic target replacement
gb|CAG39568.1|ARO:3003285|Staphylococcus_aureus_rpoB_mutants_conferring_resistance_to_rifampicin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,peptide antibiotic;rifamycin antibiotic,rifamycin-resistant beta-subunit of RNA polymerase (rpoB),Staphylococcus aureus rpoB mutants conferring resistance to rifampicin ,antibiotic target alteration;antibiotic target replacement
gb|CAG39568.1|ARO:3003287|Staphylococcus_aureus_rpoB_mutants_conferring_resistance_to_daptomycin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,peptide antibiotic;rifamycin antibiotic,daptomycin resistant beta-subunit of RNA polymerase (rpoB),Staphylococcus aureus rpoB mutants conferring resistance to daptomycin ,antibiotic target alteration
gb|BAB38333.1|ARO:3003288|Escherichia_coli_rpoB_mutants_conferring_resistance_to_rifampicin_[Escherichia_coli_O157:H7_str._Sakai]_,peptide antibiotic;rifamycin antibiotic,rifamycin-resistant beta-subunit of RNA polymerase (rpoB),Escherichia coli rpoB mutants conferring resistance to rifampicin ,antibiotic target alteration;antibiotic target replacement
gb|CAG39569.1|ARO:3003291|Staphylococcus_aureus_rpoC_conferring_resistance_to_daptomycin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,peptide antibiotic,daptomycin-resistant beta prime subunit of RNA polymerase (rpoC),Staphylococcus aureus rpoC conferring resistance to daptomycin ,antibiotic target alteration
gb|AAC75291.1|ARO:3003294|Escherichia_coli_gyrA_conferring_resistance_to_fluoroquinolones_[Escherichia_coli_str._K-12_substr._MG1655]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Escherichia coli gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|CCP42728.1|ARO:3003295|Mycobacterium_tuberculosis_gyrA_conferring_resistance_to_fluoroquinolones_[Mycobacterium_tuberculosis_H37Rv]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|WP_000819088.1|ARO:3003296|Staphylococcus_aureus_gyrA_conferring_resistance_to_fluoroquinolones_[Staphylococcus]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Staphylococcus aureus gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAL82403.1|ARO:3003297|Bartonella_bacilliformis_gyrA_conferring_resistance_to_fluoroquinolones_[Bartonella_bacilliformis]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Bartonella bacilliformis gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|CAC29514.1|ARO:3003298|Mycobaterium_leprae_gyrA_conferring_resistance_to_fluoroquinolones_[Mycobacterium_leprae_TN]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Mycobaterium leprae gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|CAG39033.1|ARO:3003301|Staphylococcus_aureus_gyrB_conferring_resistance_to_aminocoumarin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,aminocoumarin antibiotic,aminocoumarin resistant gyrB,Staphylococcus aureus gyrB conferring resistance to aminocoumarin ,antibiotic target alteration
gb|ABM44583.1|ARO:3003302|Bartonella_bacilliformis_gyrB_conferring_resistance_to_aminocoumarin_[Bartonella_bacilliformis_KC583]_,aminocoumarin antibiotic,aminocoumarin resistant gyrB,Bartonella bacilliformis gyrB conferring resistance to aminocoumarin ,antibiotic target alteration
gb|BAE77595.1|ARO:3003303|Escherichia_coli_gyrB_conferring_resistance_to_aminocoumarin_[Escherichia_coli_str._K-12_substr._W3110]_,aminocoumarin antibiotic,aminocoumarin resistant gyrB,Escherichia coli gyrB conferring resistance to aminocoumarin ,antibiotic target alteration
gb|CAC29513.1|ARO:3003304|Mycobacterium_leprae_gyrB_conferring_resistance_to_fluoroquinolone_[Mycobacterium_leprae_TN]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Mycobacterium leprae gyrB conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|WP_004025678.1|ARO:3003305|Ureaplasma_urealyticum_gyrB_conferring_resistance_to_fluoroquinolone_[Ureaplasma_urealyticum]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Ureaplasma urealyticum gyrB conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|AGG29535.1|ARO:3003306|Morganella_morganii_gyrB_conferring_resistance_to_fluoroquinolone_[Morganella_morganii_subsp._morganii_KT]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Morganella morganii gyrB conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|AAL22694.1|ARO:3003307|Salmonella_serovars_gyrB_conferring_resistance_to_fluoroquinolone_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Salmonella serovars gyrB conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|AAC76055.1|ARO:3003308|Escherichia_coli_parC_conferring_resistance_to_fluoroquinolone_[Escherichia_coli_str._K-12_substr._MG1655]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Escherichia coli parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|WP_010891786.1|ARO:3003309|Ureaplasma_urealyticum_parC_conferring_resistance_to_fluoroquinolone_[Ureaplasma_parvum]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Ureaplasma urealyticum parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|AKJ52802.1|ARO:3003310|Mycoplasma_hominis_parC_conferring_resistance_to_fluoroquinolone_[Mycoplasma_hominis]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Mycoplasma hominis parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|NP_358351.1|ARO:3003311|Streptococcus_pneumoniae_parC_conferring_resistance_to_fluoroquinolone_[Streptococcus_pneumoniae_R6]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Streptococcus pneumoniae parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|WP_001289569.1|ARO:3003312|Staphylococcus_aureus_parC_conferring_resistance_to_fluoroquinolone_[Staphylococcus]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Staphylococcus aureus parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|BAA11086.1|ARO:3003314|Staphylococcus_aureus_parE_conferring_resistance_to_aminocoumarin_[Staphylococcus_aureus_subsp._aureus_RN4220]_,aminocoumarin antibiotic,aminocoumarin resistant parE,Staphylococcus aureus parE conferring resistance to aminocoumarin ,antibiotic target alteration
gb|CAG40364.1|ARO:3003315|Staphylococcus_aureus_parE_conferring_resistance_to_fluoroquinolones_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,fluoroquinolone antibiotic,fluoroquinolone resistant parE,Staphylococcus aureus parE conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|BAE77086.1|ARO:3003316|Escherichia_coli_parE_conferring_resistance_to_fluoroquinolones_[Escherichia_coli_str._K-12_substr._W3110]_,fluoroquinolone antibiotic,fluoroquinolone resistant parE,Escherichia coli parE conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAL22055.1|ARO:3003317|Salmonella_serovars_parE_conferring_resistance_to_fluoroquinolones_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,fluoroquinolone antibiotic,fluoroquinolone resistant parE,Salmonella serovars parE conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|ADJ67256|ARO:3003319|Staphylococcus_aureus_mprF_mutations_conferring_resistance_to_daptomycin_[Staphylococcus_aureus]_,peptide antibiotic,daptomycin resistant mprF,Staphylococcus aureus mprF mutations conferring resistance to daptomycin ,antibiotic target alteration
gb|BAB95031.1|ARO:3003323|Staphylococcus_aureus_pgsA_mutations_conferring_resistance_to_daptomycin_[Staphylococcus_aureus_subsp._aureus_MW2]_,peptide antibiotic,daptomycin resistant pgsA,Staphylococcus aureus pgsA mutations conferring resistance to daptomycin ,antibiotic target alteration
gb|CDO45096.1|ARO:3003325|Mycobacterium_tuberculosis_variant_bovis_embB_mutations_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_variant_bovis_AF2122/97]_,polyamine antibiotic,ethambutol resistant embB,Mycobacterium tuberculosis variant bovis embB mutations conferring resistance to ethambutol ,antibiotic target alteration
gb|CCP46624.1|ARO:3003326|Mycobacterium_tuberculosis_embB_mutations_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,ethambutol resistant embB,Mycobacterium tuberculosis embB mutations conferring resistance to ethambutol ,antibiotic target alteration
gb|AFN51819.1|ARO:3003327|Mycobacterium_tuberculosis_mutant_embC_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,ethambutol resistant embC,Mycobacterium tuberculosis mutant embC conferring resistance to ethambutol ,antibiotic target alteration
gb|AXU66539.1|ARO:3003357|Clostridioides_difficile_EF-Tu_mutants_conferring_resistance_to_elfamycin_[Clostridioides_difficile]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Clostridioides difficile EF-Tu mutants conferring resistance to elfamycin ,antibiotic target alteration
gb|CAA67349.1|ARO:3003359|Streptomyces_cinnamoneus_EF-Tu_mutants_conferring_resistance_to_elfamycin_[Streptomyces_cinnamoneus]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Streptomyces cinnamoneus EF-Tu mutants conferring resistance to elfamycin ,antibiotic target alteration
gb|AAB39605.1|ARO:3003361|Planobispora_rosea_EF-Tu_mutants_conferring_resistance_to_inhibitor_GE2270A_[Planobispora_rosea]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A ,antibiotic target alteration
gb|AAA50993.1|ARO:3003368|Escherichia_coli_EF-Tu_mutants_conferring_resistance_to_kirromycin_[Escherichia_coli]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Escherichia coli EF-Tu mutants conferring resistance to kirromycin ,antibiotic target alteration
gb|AAN82549.1|ARO:3003369|Escherichia_coli_EF-Tu_mutants_conferring_resistance_to_Pulvomycin_[Escherichia_coli_CFT073]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin ,antibiotic target alteration
gb|AAC76364.1|ARO:3003370|Escherichia_coli_EF-Tu_mutants_conferring_resistance_to_Enacyloxin_IIa_[Escherichia_coli_str._K-12_substr._MG1655]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa ,antibiotic target alteration
gb|ABR75897.1|ARO:3003373|Klebsiella_pneumoniae_acrR_with_mutation_conferring_multidrug_antibiotic_resistance_[Klebsiella_pneumoniae_subsp._pneumoniae_MGH_78578]_,cephalosporin;fluoroquinolone antibiotic;glycylcycline;penam;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,resistance-nodulation-cell division (RND) antibiotic efflux pump,Klebsiella pneumoniae acrR with mutation conferring multidrug antibiotic resistance ,antibiotic efflux;antibiotic target alteration
gb|CAC35723.1|ARO:3003374|Klebsiella_aerogenes_acrR_with_mutation_conferring_multidrug_antibiotic_resistance_[Klebsiella_aerogenes]_,cephalosporin;fluoroquinolone antibiotic;glycylcycline;penam;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,resistance-nodulation-cell division (RND) antibiotic efflux pump,Klebsiella aerogenes acrR with mutation conferring multidrug antibiotic resistance ,antibiotic efflux;antibiotic target alteration
gb|ACH50230.1|ARO:3003379|Salmonella_enterica_ramR_mutants_[Salmonella_enterica_subsp._enterica_serovar_Agona_str._SL483]_,cephalosporin;fluoroquinolone antibiotic;glycylcycline;penam;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,resistance-nodulation-cell division (RND) antibiotic efflux pump,Salmonella enterica ramR mutants ,antibiotic efflux;antibiotic target alteration
gb|ABR76005.1|ARO:3003380|Klebsiella_pneumoniae_ramR_mutants_[Klebsiella_pneumoniae_subsp._pneumoniae_MGH_78578]_,cephalosporin;fluoroquinolone antibiotic;glycylcycline;penam;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,resistance-nodulation-cell division (RND) antibiotic efflux pump,Klebsiella pneumoniae ramR mutants ,antibiotic efflux;antibiotic target alteration
gb|CAD09250.1|ARO:3003382|Salmonella_enterica_soxR_with_mutation_conferring_antibiotic_resistance_[Salmonella_enterica_subsp._enterica_serovar_Typhi_str._CT18]_,cephalosporin;fluoroquinolone antibiotic;glycylcycline;penam;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,ATP-binding cassette (ABC) antibiotic efflux pump;major facilitator superfamily (MFS) antibiotic efflux pump;resistance-nodulation-cell division (RND) antibiotic efflux pump,Salmonella enterica soxR with mutation conferring antibiotic resistance ,antibiotic efflux;antibiotic target alteration
gb|AAL23089.1|ARO:3003383|Salmonella_serovars_soxS_with_mutation_conferring_antibiotic_resistance_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,carbapenem;cephalosporin;cephamycin;fluoroquinolone antibiotic;glycylcycline;monobactam;penam;penem;phenicol antibiotic;rifamycin antibiotic;tetracycline antibiotic;triclosan,ATP-binding cassette (ABC) antibiotic efflux pump;General Bacterial Porin with reduced permeability to beta-lactams;major facilitator superfamily (MFS) antibiotic efflux pump;resistance-nodulation-cell division (RND) antibiotic efflux pump,Salmonella serovars soxS with mutation conferring antibiotic resistance ,antibiotic efflux;antibiotic target alteration;reduced permeability to antibiotic
gb|AAK11270.1|ARO:3003385|Klebsiella_aerogenes_omp36_with_mutation_[Klebsiella_aerogenes]_,carbapenem;cephalosporin;cephamycin;monobactam;penam;penem,General Bacterial Porin with reduced permeability to beta-lactams,Klebsiella aerogenes omp36 with mutation ,reduced permeability to antibiotic
gb|AAC76209.2|ARO:3003386|Escherichia_coli_folP_with_mutation_conferring_resistance_to_sulfonamides_[Escherichia_coli_str._K-12_substr._MG1655]_,sulfonamide antibiotic;sulfone antibiotic,sulfonamide resistant dihydropteroate synthase folP,Escherichia coli folP with mutation conferring resistance to sulfonamides ,antibiotic target alteration
gb|AAL97684.1|ARO:3003387|Streptococcus_pyogenes_folP_with_mutation_conferring_resistance_to_sulfonamides_[Streptococcus_pyogenes_MGAS8232]_,sulfonamide antibiotic;sulfone antibiotic,sulfonamide resistant dihydropteroate synthase folP,Streptococcus pyogenes folP with mutation conferring resistance to sulfonamides ,antibiotic target alteration
gb|CAC29732.1|ARO:3003389|Mycobacterium_leprae_folP_with_mutation_conferring_resistance_to_dapsone_[Mycobacterium_leprae_TN]_,sulfonamide antibiotic;sulfone antibiotic,dapsone resistant dihydropteroate synthase folP,Mycobacterium leprae folP with mutation conferring resistance to dapsone ,antibiotic target alteration
gb|AAC74015.1|ARO:3003390|Pseudomonas_aeruginosa_ompF_with_mutation_[Escherichia_coli_str._K-12_substr._MG1655]_,carbapenem;cephalosporin;cephamycin;monobactam;penam;penem,General Bacterial Porin with reduced permeability to beta-lactams,Pseudomonas aeruginosa ompF with mutation ,reduced permeability to antibiotic
gb|CCP44675.1|ARO:3003392|Mycobacterium_tuberculosis_katG_mutations_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,isoniazid,isoniazid resistant katG,Mycobacterium tuberculosis katG mutations conferring resistance to isoniazid ,antibiotic target alteration
gb|CCP44244.1|ARO:3003393|Mycobacterium_tuberculosis_inhA_mutations_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,isoniazid;triclosan,isoniazid resistant inhA,Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid ,antibiotic target alteration
gb|CCP44816.1|ARO:3003394|Mycobacterium_tuberculosis_pncA_mutations_conferring_resistance_to_pyrazinamide_[Mycobacterium_tuberculosis_H37Rv]_,pyrazinamide,pyrazinamide resistant pncA,Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide ,antibiotic target alteration
gb|AAK44936.1|ARO:3003395|Mycobacterium_tuberculosis_rpsL_mutations_conferring_resistance_to_Streptomycin_[Mycobacterium_tuberculosis_CDC1551]_,aminoglycoside antibiotic,antibiotic-resistant rpsL,Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin ,antibiotic target alteration
gb|AFK57679.1|ARO:3003438|Enterococcus_faecium_EF-Tu_mutants_conferring_resistance_to_GE2270A_[Enterococcus_faecium_DO]_,elfamycin antibiotic,elfamycin resistant EF-Tu,Enterococcus faecium EF-Tu mutants conferring resistance to GE2270A ,antibiotic target alteration
gb|AAK46002.1|ARO:3003445|Mycobacterium_tuberculosis_tlyA_mutations_conferring_resistance_to_aminoglycosides_[Mycobacterium_tuberculosis_CDC1551]_,aminoglycoside antibiotic,Antibiotic resistant tlyA,Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides ,antibiotic target alteration
gb|CCP43072.1|ARO:3003448|Mycobacterium_tuberculosis_iniA_mutant_conferring_resistance_to_Ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,Ethambutol resistant iniA,Mycobacterium tuberculosis iniA mutant conferring resistance to Ethambutol ,antibiotic efflux;antibiotic target alteration
gb|CCP43073.1|ARO:3003451|Mycobacterium_tuberculosis_iniC_mutant_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,Ethambutol resistant iniC,Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol ,antibiotic efflux;antibiotic target alteration
gb|AFN51820.1|ARO:3003453|Mycobacterium_tuberculosis_embA_mutant_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,ethambutol resistant embA,Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol ,antibiotic target alteration
gb|CCP44023.1|ARO:3003455|Mycobacterium_tuberculosis_embR_mutant_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,ethambutol resistant embR,Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol ,antibiotic target alteration
gb|AAK48336.1|ARO:3003458|Mycobacterium_tuberculosis_ethA_with_mutation_conferring_resistance_to_ethionamide_[Mycobacterium_tuberculosis_CDC1551]_,ethionamide;isoniazid,ethionamide resistant ethA,Mycobacterium tuberculosis ethA with mutation conferring resistance to ethionamide ,antibiotic target alteration
gb|CAA55486.1|ARO:3003459|Mycobacterium_tuberculosis_gyrB_mutant_conferring_resistance_to_fluoroquinolone_[Mycobacterium_tuberculosis_H37Ra]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|CCP44620.1|ARO:3003461|Mycobacterium_tuberculosis_ndh_mutant_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,isoniazid,antibiotic resistant ndh,Mycobacterium tuberculosis ndh mutant conferring resistance to isoniazid ,antibiotic target alteration
gb|CCP45025.1|ARO:3003463|Mycobacterium_tuberculosis_kasA_mutant_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,isoniazid;triclosan,antibiotic resistant kasA,Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid ,antibiotic target alteration
gb|AAK48268.1|ARO:3003465|Mycobacterium_tuberculosis_embB_mutants_conferring_resistance_to_rifampicin_[Mycobacterium_tuberculosis_CDC1551]_,polyamine antibiotic;rifamycin antibiotic,rifamycin-resistant arabinosyltransferase,Mycobacterium tuberculosis embB mutants conferring resistance to rifampicin ,antibiotic target alteration
gb|CCP46748.1|ARO:3003470|Mycobacterium_tuberculosis_gidB_mutation_conferring_resistance_to_streptomycin_[Mycobacterium_tuberculosis_H37Rv]_,aminoglycoside antibiotic,antibiotic resistant gidB,Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin ,antibiotic target alteration
gb|AJF82049.1|ARO:3003573|LpxA_[Acinetobacter_baumannii]_,peptide antibiotic,Acinetobacter mutant Lpx gene conferring resistance to colistin,LpxA ,antibiotic target alteration
gb|AJF83452.1|ARO:3003574|LpxC_[Acinetobacter_baumannii]_,peptide antibiotic,Acinetobacter mutant Lpx gene conferring resistance to colistin,LpxC ,antibiotic target alteration
gb|AAG08162.1|ARO:3003582|basR_[Pseudomonas_aeruginosa_PAO1]_,peptide antibiotic,pmr phosphoethanolamine transferase,basR ,antibiotic efflux;antibiotic target alteration
gb|CDO13981.1|ARO:3003585|Klebsiella_mutant_PhoP_conferring_antibiotic_resistance_to_colistin_[Klebsiella_pneumoniae]_,macrolide antibiotic;peptide antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump;pmr phosphoethanolamine transferase,Klebsiella mutant PhoP conferring antibiotic resistance to colistin ,antibiotic efflux;antibiotic target alteration
gb|AAG06556.1|ARO:3003684|Pseudomonas_aeruginosa_gyrA_conferring_resistance_to_fluoroquinolones_[Pseudomonas_aeruginosa_PAO1]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Pseudomonas aeruginosa gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAG08352.1|ARO:3003685|Pseudomonas_aeruginosa_parE_conferring_resistance_to_fluoroquinolones_[Pseudomonas_aeruginosa_PAO1]_,fluoroquinolone antibiotic,fluoroquinolone resistant parE,Pseudomonas aeruginosa parE conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAG04347.1|ARO:3003686|Pseudomonas_aeruginosa_oprD_with_mutation_conferring_resistance_to_imipenem_[Pseudomonas_aeruginosa_PAO1]_,carbapenem;cephalosporin;cephamycin;monobactam;penam;penem,Outer Membrane Porin (Opr),Pseudomonas aeruginosa oprD with mutation conferring resistance to imipenem ,reduced permeability to antibiotic
gb|BAA37152.1|ARO:3003702|Pseudomonas_aeruginosa_gyrA_and_parC_conferring_resistance_to_fluoroquinolone_[Pseudomonas_aeruginosa]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Pseudomonas aeruginosa gyrA and parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|CAA52296.1|ARO:3003729|Staphylococcus_aureus_ileS_with_mutation_conferring_resistance_to_mupirocin_[Staphylococcus_aureus]_,mupirocin,antibiotic-resistant isoleucyl-tRNA synthetase (ileS),Staphylococcus aureus ileS with mutation conferring resistance to mupirocin ,antibiotic target alteration
gb|CAG39573|ARO:3003735|Staphylococcus_mutant_fusA_gene_conferring_resistance_to_fusidic_acid_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,fusidic acid,antibiotic resistant fusA,Staphylococcus mutant fusA gene conferring resistance to fusidic acid ,antibiotic target alteration
gb|ADL24064.1|ARO:3003737|Staphylococcus_mutant_fusE_gene_conferring_resistance_to_fusidic_acid_[Staphylococcus_aureus_subsp._aureus_JKD6159]_,fusidic acid,antibiotic resistant fusE,Staphylococcus mutant fusE gene conferring resistance to fusidic acid ,antibiotic target alteration
gb|AAC73938.1|ARO:3003751|Escherichia_coli_nfsA_mutations_conferring_resistance_to_nitrofurantoin_[Escherichia_coli_str._K-12_substr._MG1655]_,nitrofuran antibiotic,antibiotic resistant nfsA,Escherichia coli nfsA mutations conferring resistance to nitrofurantoin ,antibiotic target alteration
gb|AEA93051.1|ARO:3003760|Enterococcus_faecalis_cls_conferring_resistance_to_daptomycin_[Enterococcus_faecalis_OG1RF]_,peptide antibiotic,daptomycin resistant cls,Enterococcus faecalis cls conferring resistance to daptomycin ,antibiotic target alteration
gb|AGQ48857.1|ARO:3003761|eatAv_[Enterococcus_faecium]_,lincosamide antibiotic;macrolide antibiotic;oxazolidinone antibiotic;phenicol antibiotic;pleuromutilin antibiotic;streptogramin antibiotic;tetracycline antibiotic,ABC-F ATP-binding cassette ribosomal protection protein,eatAv ,antibiotic target protection
gb|ADJ67256.1|ARO:3003769|Staphylococcus_aureus_mprF_[Staphylococcus_aureus]_,peptide antibiotic,defensin resistant mprF,Staphylococcus aureus mprF ,antibiotic target alteration
gb|AIL15701|ARO:3003775|Escherichia_coli_murA_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_ATCC_25922]_,fosfomycin,antibiotic-resistant murA transferase,Escherichia coli murA with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CAG41169.1|ARO:3003776|Staphylococcus_aureus_murA_with_mutation_conferring_resistance_to_fosfomycin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,fosfomycin,antibiotic-resistant murA transferase,Staphylococcus aureus murA with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|AAC66824.2|ARO:3003777|Borreliella_burgdorferi_murA_with_mutation_conferring_resistance_to_fosfomycin_[Borreliella_burgdorferi_B31]_,fosfomycin,antibiotic-resistant murA transferase,Borreliella burgdorferi murA with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|AIU22003.1|ARO:3003778|Mycolicibacterium_smegmatis_mutant_ndh_conferring_resistance_to_isoniazid_[Mycolicibacterium_smegmatis]_,isoniazid,antibiotic resistant ndh,Mycolicibacterium smegmatis mutant ndh conferring resistance to isoniazid ,antibiotic target alteration
gb|CAL71877.1|ARO:3003779|Mycobacterium_tuberculosis_variant_bovis_mutant_ndh_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_variant_bovis_BCG_str._Pasteur_1173P2]_,isoniazid,antibiotic resistant ndh,Mycobacterium tuberculosis variant bovis mutant ndh conferring resistance to isoniazid ,antibiotic target alteration
gb|CCE36834|ARO:3003784|Mycobacterium_tuberculosis_intrinsic_murA_conferring_resistance_to_fosfomycin_[Mycobacterium_tuberculosis_UT205]_,fosfomycin,antibiotic-resistant murA transferase,Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin ,antibiotic target alteration
gb|BAA85265|ARO:3003788|Bacillus_subtilis_pgsA_mutations_conferring_resistance_to_daptomycin_[Bacillus_subtilis]_,peptide antibiotic,daptomycin resistant pgsA,Bacillus subtilis pgsA mutations conferring resistance to daptomycin ,antibiotic target alteration
gb|CAL35145.1|ARO:3003789|Campylobacter_jejuni_gyrA_conferring_resistance_to_fluoroquinolones_[Campylobacter_jejuni_subsp._jejuni_NCTC_11168_=_ATCC_700819]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Campylobacter jejuni gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|CUX99269.1|ARO:3003790|Enterococcus_faecium_liaF_mutant_conferring_daptomycin_resistance_[Enterococcus_faecium]_,peptide antibiotic,daptomycin resistant liaF,Enterococcus faecium liaF mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|AAO82600.1|ARO:3003791|Enterococcus_faecalis_liaS_mutant_conferring_daptomycin_resistance_[Enterococcus_faecalis_V583]_,peptide antibiotic,daptomycin resistant liaS,Enterococcus faecalis liaS mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|AAO82599.1|ARO:3003792|Enterococcus_faecalis_liaR_mutant_conferring_daptomycin_resistance_[Enterococcus_faecalis_V583]_,peptide antibiotic,daptomycin resistant liaR,Enterococcus faecalis liaR mutant conferring daptomycin resistance ,antibiotic efflux;antibiotic target alteration
gb|CAG39047|ARO:3003794|Staphylococcus_aureus_walK_with_mutation_conferring_daptomycin_resistance_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,peptide antibiotic,daptomycin resistant walK,Staphylococcus aureus walK with mutation conferring daptomycin resistance ,antibiotic target alteration
gb|AAO79895.1|ARO:3003797|Enterococcus_faecalis_YybT_with_mutation_conferring_daptomycin_resistance_[Enterococcus_faecalis_V583]_,peptide antibiotic,daptomycin resistant YybT,Enterococcus faecalis YybT with mutation conferring daptomycin resistance ,antibiotic target alteration
gb|AMR95642.1|ARO:3003805|Enterococcus_faecalis_gshF_with_mutation_conferring_daptomycin_resistance_[Enterococcus_faecalis]_,peptide antibiotic,daptomycin resistant gshF,Enterococcus faecalis gshF with mutation conferring daptomycin resistance ,antibiotic target alteration
gb|AJF82744.1|ARO:3003817|Acinetobacter_baumannii_gyrA_conferring_resistance_to_fluoroquinolones_[Acinetobacter_baumannii]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Acinetobacter baumannii gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|WP_000202252.1|ARO:3003818|Acinetobacter_baumannii_parC_conferring_resistance_to_fluoroquinolone_[Acinetobacter]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Acinetobacter baumannii parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|CDJ72593|ARO:3003889|Escherichia_coli_GlpT_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_str._K-12_substr._MC4100]_,fosfomycin,antibiotic-resistant GlpT,Escherichia coli GlpT with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CDJ73208|ARO:3003890|Escherichia_coli_UhpT_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_str._K-12_substr._MC4100]_,fosfomycin,antibiotic-resistant UhpT,Escherichia coli UhpT with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CDJ73205|ARO:3003893|Escherichia_coli_UhpA_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_str._K-12_substr._MC4100]_,fosfomycin,antibiotic-resistant UhpT,Escherichia coli UhpA with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|AAG04568.1|ARO:3003895|Pseudomonas_mutant_PhoP_conferring_resistance_to_colistin_[Pseudomonas_aeruginosa_PAO1]_,macrolide antibiotic;peptide antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump;pmr phosphoethanolamine transferase,Pseudomonas mutant PhoP conferring resistance to colistin ,antibiotic efflux;antibiotic target alteration
gb|AAG04569.1|ARO:3003896|Pseudomonas_mutant_PhoQ_conferring_resistance_to_colistin_[Pseudomonas_aeruginosa_PAO1]_,macrolide antibiotic;peptide antibiotic,ATP-binding cassette (ABC) antibiotic efflux pump;pmr phosphoethanolamine transferase,Pseudomonas mutant PhoQ conferring resistance to colistin ,antibiotic efflux;antibiotic target alteration
gb|CDJ72759|ARO:3003899|Escherichia_coli_PtsI_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_str._K-12_substr._MC4100]_,fosfomycin,antibiotic-resistant ptsI phosphotransferase,Escherichia coli PtsI with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CDJ73082|ARO:3003900|Escherichia_coli_CyaA_with_mutation_conferring_resistance_to_fosfomycin_[Escherichia_coli_str._K-12_substr._MC4100]_,fosfomycin,antibiotic-resistant cya adenylate cyclase,Escherichia coli CyaA with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CAG39357|ARO:3003901|Staphylococcus_aureus_GlpT_with_mutation_conferring_resistance_to_fosfomycin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,fosfomycin,antibiotic-resistant GlpT,Staphylococcus aureus GlpT with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|CAG39240|ARO:3003902|Staphylococcus_aureus_UhpT_with_mutation_conferring_resistance_to_fosfomycin_[Staphylococcus_aureus_subsp._aureus_MRSA252]_,fosfomycin,antibiotic-resistant UhpT,Staphylococcus aureus UhpT with mutation conferring resistance to fosfomycin ,antibiotic target alteration
gb|ABD30105.1|ARO:3003917|Staphylococcus_aureus_menA_with_mutation_conferring_resistance_to_lysocin_[Staphylococcus_aureus_subsp._aureus_NCTC_8325]_,peptide antibiotic,lysocin resistant menA,Staphylococcus aureus menA with mutation conferring resistance to lysocin ,antibiotic target alteration
gb|CBW16027.1|ARO:3003924|Haemophilus_parainfluenzae_gyrA_conferring_resistance_to_fluoroquinolones_[Haemophilus_parainfluenzae_T3T1]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Haemophilus parainfluenzae gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|WP_041918279.1|ARO:3003925|Haemophilus_parainfluenzae_parC_conferring_resistance_to_fluoroquinolones_[Haemophilus_parainfluenzae]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Haemophilus parainfluenzae parC conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAL21173.1|ARO:3003926|Salmonella_enterica_gyrA_conferring_resistance_to_fluoroquinolones_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Salmonella enterica gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAW89357.1|ARO:3003928|Neisseria_gonorrhoeae_gyrA_conferring_resistance_to_fluoroquinolones_[Neisseria_gonorrhoeae_FA_1090]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Neisseria gonorrhoeae gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAW89918.1|ARO:3003929|Neisseria_gonorrhoeae_parC_conferring_resistance_to_fluoroquinolone_[Neisseria_gonorrhoeae_FA_1090]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Neisseria gonorrhoeae parC conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|AAW90462.1|ARO:3003930|rpsJ_[Neisseria_gonorrhoeae_FA_1090]_,tetracycline antibiotic,tetracycline-resistant ribosomal protection protein,rpsJ ,antibiotic target protection
gb|EEK14408.1|ARO:3003931|Capnocytophaga_gingivalis_gyrA_conferring_resistance_to_fluoroquinolones_[Capnocytophaga_gingivalis_ATCC_33624]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Capnocytophaga gingivalis gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAF40852.1|ARO:3003937|Neisseria_meningititis_PBP2_conferring_resistance_to_beta-lactam_[Neisseria_meningitidis_MC58]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Neisseria meningititis PBP2 conferring resistance to beta-lactam ,antibiotic target alteration
gb|AAL22048.1|ARO:3003939|Salmonella_enterica_parC_conferring_resistance_to_fluoroquinolones_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Salmonella enterica parC conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAN43827.1|ARO:3003940|Shigella_flexneri_gyrA_conferring_resistance_to_fluoroquinolones_[Shigella_flexneri_2a_str._301]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Shigella flexneri gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAN44541.1|ARO:3003941|Shigella_flexneri_parC_conferring_resistance_to_fluoroquinolones_[Shigella_flexneri_2a_str._301]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Shigella flexneri parC conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAN62561.1|ARO:3003970|D-Ala-D-Ala_ligase_[Enterococcus_gallinarum]_,glycopeptide antibiotic,van ligase,D-Ala-D-Ala ligase ,antibiotic target alteration
gb|AER05434.1|ARO:3003974|Cutibacterium_acnes_gyrA_conferring_resistance_to_fluoroquinolones_[Cutibacterium_acnes_subsp._defendens_ATCC_11828]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Cutibacterium acnes gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|CAJ66820.1|ARO:3003995|Clostridioides_difficile_gyrA_conferring_resistance_to_fluoroquinolones_[Clostridioides_difficile_630]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Clostridioides difficile gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|AAC74370.1|ARO:3004045|antibiotic_resistant_fabI_[Escherichia_coli_str._K-12_substr._MG1655]_,isoniazid;triclosan,antibiotic resistant fabI,antibiotic resistant fabI ,antibiotic target alteration
gb|AAC74177.1|ARO:3004049|antibiotic_resistant_fabG_[Escherichia_coli_str._K-12_substr._MG1655]_,triclosan,antibiotic resistant fabG,antibiotic resistant fabG ,antibiotic target alteration
gb|AQA08261.1|ARO:3004097|Streptococcus_mitis_CdsA_with_mutation_conferring_daptomycin_resistance_[Streptococcus_oralis]_,peptide antibiotic,daptomycin resistant CdsA,Streptococcus mitis CdsA with mutation conferring daptomycin resistance ,antibiotic target alteration
gb|CCP43071.1|ARO:3004135|Mycobacterium_tuberculosis_iniB_with_mutation_conferring_resistance_to_ethambutol_[Mycobacterium_tuberculosis_H37Rv]_,polyamine antibiotic,Ethambutol resistant iniB,Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol ,antibiotic efflux;antibiotic target alteration
gb|EGP45233.1|ARO:3004145|AxyZ_[Achromobacter_insuavis_AXX-A]_,aminoglycoside antibiotic;cephalosporin;fluoroquinolone antibiotic;macrolide antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump,AxyZ ,antibiotic efflux;antibiotic target alteration
gb|CCP45563.1|ARO:3004153|Mycobacterium_tuberculosis_thyA_with_mutation_conferring_resistance_to_para-aminosalicylic_acid_[Mycobacterium_tuberculosis_H37Rv]_,para-aminosalicylic acid,aminosalicylate resistant thymidylate synthase,Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid ,antibiotic target alteration
gb|CCP45240.1|ARO:3004157|Mycobacterium_tuberculosis_folC_with_mutation_conferring_resistance_to_para-aminosalicylic_acid_[Mycobacterium_tuberculosis_H37Rv]_,para-aminosalicylic acid,aminosalicylate resistant dihydrofolate synthase,Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid ,antibiotic target alteration
gb|CCP45469.1|ARO:3004184|Mycobacterium_tuberculosis_ribD_with_mutation_conferring_resistance_to_para-aminosalicylic_acid_[Mycobacterium_tuberculosis_H37Rv]_,para-aminosalicylic acid,aminosalicylate resistant dihydrofolate reductase,Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid ,antibiotic target replacement
gb|AAL21173.1|ARO:3004334|Salmonella_enterica_gyrA_with_mutation_conferring_resistance_to_triclosan_[Salmonella_enterica_subsp._enterica_serovar_Typhimurium_str._LT2]_,triclosan,triclosan resistant gyrA,Salmonella enterica gyrA with mutation conferring resistance to triclosan ,antibiotic target alteration
gb|AAC75291.1|ARO:3004335|Escherichia_coli_gyrA_with_mutation_conferring_resistance_to_triclosan_[Escherichia_coli_str._K-12_substr._MG1655]_,triclosan,triclosan resistant gyrA,Escherichia coli gyrA with mutation conferring resistance to triclosan ,antibiotic target alteration
gb|AAC22787.1|ARO:3004446|Haemophilus_influenzae_PBP3_conferring_resistance_to_beta-lactam_antibiotics_[Haemophilus_influenzae_Rd_KW20]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics ,antibiotic target alteration
gb|AAK80188.1|ARO:3004561|Clostridioides_difficile_murG_with_mutation_conferring_resistance_to_vancomycin_[Clostridium_acetobutylicum_ATCC_824]_,glycopeptide antibiotic,murG transferase,Clostridioides difficile murG with mutation conferring resistance to vancomycin ,antibiotic target alteration
gb|ADK13120.1|ARO:3004562|Clostridioides_difficile_gyrB_conferring_resistance_to_fluoroquinolone_[Clostridium_ljungdahlii_DSM_13528]_,aminocoumarin antibiotic;fluoroquinolone antibiotic,fluoroquinolone resistant gyrB,Clostridioides difficile gyrB conferring resistance to fluoroquinolone ,antibiotic target alteration
gb|ADK17136.1|ARO:3004563|Clostridioides_difficile_rpoB_with_mutation_conferring_resistance_to_rifampicin_[Clostridium_ljungdahlii_DSM_13528]_,peptide antibiotic;rifamycin antibiotic,rifamycin-resistant beta-subunit of RNA polymerase (rpoB),Clostridioides difficile rpoB with mutation conferring resistance to rifampicin ,antibiotic target alteration;antibiotic target replacement
gb|WP_010869372.1|ARO:3004630|Mycoplasma_Genitalium_parC_mutations_confers_resistance_to_Moxifloxacin_[Mycoplasma_genitalium]_,fluoroquinolone antibiotic,fluoroquinolone resistant parC,Mycoplasma Genitalium parC mutations confers resistance to Moxifloxacin ,antibiotic target alteration
gb|AAC71220.1|ARO:3004631|Mycoplasma_Genitalium_GyrA_mutation_confers_resistance_to_fluoroquinolones_[Mycoplasma_genitalium_G37]_,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Mycoplasma Genitalium GyrA mutation confers resistance to fluoroquinolones ,antibiotic target alteration
gb|AJP09758.1|ARO:3004681|Clostridioides_difficile_rpoC_with_mutation_conferring_resistance_to_vancomycin_[Clostridioides_difficile_630]_,glycopeptide antibiotic,vancomycin-resistant beta prime subunit of RNA polymerase (rpoC),Clostridioides difficile rpoC with mutation conferring resistance to vancomycin ,antibiotic target alteration
gb|CCP44394.1|ARO:3004721|Mycobacterium_tuberculosis_rpsA_mutations_conferring_resistance_to_Pyrazinamide_[Mycobacterium_tuberculosis_H37Rv]_,pyrazinamide,pyrazinamide resistant rpsA,Mycobacterium tuberculosis rpsA mutations conferring resistance to Pyrazinamide ,antibiotic target alteration
gb|AAA25463.1|ARO:3004832|Neisseria_gonorrhoeae_PBP2_conferring_resistance_to_beta-lactam_antibiotics_[Neisseria_gonorrhoeae]_Partial,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Neisseria gonorrhoeae PBP2 conferring resistance to beta-lactam antibiotics ,antibiotic target alteration
gb|AAB52541.1|ARO:3004833|Neisseria_gonorrhoea_PBP1_conferring_resistance_to_beta-lactam_[Neisseria_meningitidis]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Neisseria gonorrhoea PBP1 conferring resistance to beta-lactam ,antibiotic target alteration
gb|VEG60537.1|ARO:3004835|Neisseria_gonorrhoea_pilQ_gene_conferring_resistance_to_beta-lactam_[Neisseria_gonorrhoeae]_,carbapenem;cephalosporin;cephamycin;monobactam;penam,Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics,Neisseria gonorrhoea pilQ gene conferring resistance to beta-lactam ,antibiotic target alteration
gb|ACF30254.1|ARO:3004851|Neisseria_gonorrhoea_mtrR_with_mutation_conferring_resistance_[Neisseria_gonorrhoeae_NCCP11945]_Partial,macrolide antibiotic,resistance-nodulation-cell division (RND) antibiotic efflux pump,Neisseria gonorrhoea mtrR with mutation conferring resistance ,antibiotic efflux
gb|WP_050171206|ARO:3004859|Neisseria_gonorrhoeae_gyrB_conferring_resistance_to_zoliflodacin_[Neisseria_gonorrhoeae]_Partial,Zoliflodacin;aminocoumarin antibiotic,Zoliflodacin resistant gyrB,Neisseria gonorrhoeae gyrB conferring resistance to zoliflodacin ,antibiotic target alteration
gb|AJY14066.1|ARO:3004860|Burkholderia_dolosa_gyrA_conferring_resistance_to_fluoroquinolones_[Burkholderia_dolosa_AU0158]_Partial,fluoroquinolone antibiotic;nybomycin,fluoroquinolone resistant gyrA,Burkholderia dolosa gyrA conferring resistance to fluoroquinolones ,antibiotic target alteration
gb|KAE9504908.1|ARO:3004873|Neisseria_gonorrhoeae_folP_with_mutation_conferring_resistance_to_sulfonamides_[Neisseria_gonorrhoeae]_,sulfonamide antibiotic;sulfone antibiotic,sulfonamide resistant dihydropteroate synthase folP,Neisseria gonorrhoeae folP with mutation conferring resistance to sulfonamides ,antibiotic target alteration
gb|CCP43220.1|ARO:3004925|Mycobacterium_tuberculosis_mshA_mutations_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,isoniazid,isoniazid resistant mshA,Mycobacterium tuberculosis mshA mutations conferring resistance to isoniazid ,antibiotic target alteration
gb|YP_208871|ARO:3004956|rpld_[Neisseria_gonorrhoeae_FA_1090]_Partial,glycopeptide antibiotic;macrolide antibiotic,50S rRNA with mutation conferring resistance to macrolide antibiotics,rpld ,antibiotic target alteration
gb|AAS81670.1|ARO:3005081|Thermus_thermophilus_uL3_mutations_conferring_resistance_to_pleuromutilin_antibiotics_[Thermus_thermophilus_HB27]_,pleuromutilin antibiotic,Ribosomal protein mutation conferring resistance to pleuromutilin antibiotics,Thermus thermophilus uL3 mutations conferring resistance to pleuromutilin antibiotics ,antibiotic target alteration
gb|CCP44675.1|ARO:3005102|Mycobacterium_tuberculosis_katG_mutations_conferring_resistance_to_prothionamide_[Mycobacterium_tuberculosis_H37Rv]_,prothionamide,prothionamide resistant katG,Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide ,antibiotic target alteration
gb|NP_218371.1|ARO:3005105|Mycobacterium_tuberculosis_ethA_mutations_conferring_resistance_to_isoniazid_[Mycobacterium_tuberculosis_H37Rv]_,ethionamide;isoniazid,isoniazid resistant ethA,Mycobacterium tuberculosis ethA mutations conferring resistance to isoniazid ,antibiotic target alteration
gb|NP_218371.1|ARO:3005106|Mycobacterium_tuberculosis_ethA_mutations_conferring_resistance_to_prothionamide_[Mycobacterium_tuberculosis_H37Rv]_,ethionamide;isoniazid;prothionamide,prothionamide resistant ethA,Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide ,antibiotic target alteration
gb|NP_215000.1|ARO:3005108|Mycobacterium_tuberculosis_mshA_mutations_conferring_resistance_to_prothionamide_[Mycobacterium_tuberculosis_H37Rv]_,prothionamide,prothionamide resistant mshA,Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide ,antibiotic target alteration